NASDAQ:BLFS BioLife Solutions (BLFS) Stock Price, News & Analysis $22.30 +1.54 (+7.42%) Closing price 04:00 PM EasternExtended Trading$22.31 +0.01 (+0.04%) As of 04:23 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About BioLife Solutions Stock (NASDAQ:BLFS) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get BioLife Solutions alerts:Sign Up Key Stats Today's Range$20.69▼$22.7250-Day Range$18.15▼$23.1252-Week Range$17.86▼$29.62Volume946,259 shsAverage Volume407,143 shsMarket Capitalization$1.09 billionP/E RatioN/ADividend YieldN/APrice Target$32.00Consensus RatingHold Company Overview BioLife Solutions (NASDAQ:BLFS) specializes in biopreservation and cold chain workflow solutions for cell and gene therapies, regenerative medicine and other advanced biologics. The company develops and markets proprietary cryopreservation media and technology platforms designed to maintain cell viability and functionality during processing, storage and transport. BioLife’s product portfolio addresses critical steps in the manufacturing and distribution of cell-based products, helping life science researchers and biopharmaceutical manufacturers protect and preserve living cells. The company’s flagship offerings include CryoStor, a family of serum-free cryopreservation media; HypoThermosol, a hypothermic storage solution for short-term cell and tissue preservation; and the ThawSTAR system, an automated cell thawing instrument that delivers controlled and reproducible warming of frozen cell therapies. In addition to its core media and instrumentation, BioLife provides technical support, training and validation services to help customers integrate its products into regulated processes and meet GMP-compliance requirements. Headquartered in Bothell, Washington, BioLife Solutions serves a global customer base spanning academic research centers, contract development and manufacturing organizations (CDMOs) and commercial biopharmaceutical companies. The company has established distribution channels in North America, Europe and Asia to support the growing demand for standardized, clinical-grade preservation solutions. BioLife’s management team is led by President and Chief Executive Officer Warren T. Thompson, whose experience in the life sciences industry has guided strategic product development and expansion initiatives. Through continuous innovation in biopreservation technologies, BioLife Solutions aims to enable the safe and reliable delivery of next-generation cell therapies worldwide.AI Generated. May Contain Errors. Read More BioLife Solutions Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks54th Percentile Overall ScoreBLFS MarketRank™: BioLife Solutions scored higher than 54% of companies evaluated by MarketBeat, and ranked 423rd out of 859 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingHold Consensus RatingBioLife Solutions has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on no strong buy ratings, 3 buy ratings, 1 hold rating, and 1 sell rating.Upside PotentialBioLife Solutions has a consensus price target of $32.00, representing about 42.3% upside from its current price of $22.49.Amount of Analyst CoverageBioLife Solutions has only been the subject of 2 research reports in the past 90 days.Read more about BioLife Solutions' stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth177.78% Earnings GrowthEarnings for BioLife Solutions are expected to grow by 177.78% in the coming year, from $0.09 to $0.25 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of BioLife Solutions is -280.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of BioLife Solutions is -280.30, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioBioLife Solutions has a P/B Ratio of 2.91. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about BioLife Solutions' valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted7.59% of the float of BioLife Solutions has been sold short.Short Interest Ratio / Days to CoverBioLife Solutions has a short interest ratio ("days to cover") of 9.15.Change versus previous monthShort interest in BioLife Solutions has recently increased by 8.98%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldBioLife Solutions does not currently pay a dividend.Dividend GrowthBioLife Solutions does not have a long track record of dividend growth. News and Social Media1.5 / 5News Sentiment0.45 News SentimentBioLife Solutions has a news sentiment score of 0.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.59 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 4 news articles for BioLife Solutions this week, compared to 4 articles on an average week. Company Ownership1.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, BioLife Solutions insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,009,000.00 in company stock.Percentage Held by Insiders2.20% of the stock of BioLife Solutions is held by insiders.Percentage Held by Institutions93.24% of the stock of BioLife Solutions is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about BioLife Solutions' insider trading history. Receive BLFS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BioLife Solutions and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BLFS Stock News HeadlinesBioLife Solutions Earnings Call Highlights Growth PathMay 13, 2026 | theglobeandmail.comBioLife Solutions (NASDAQ:BLFS) vs. Akanda (NASDAQ:AKAN) Financial ContrastMay 12, 2026 | americanbankingnews.comRead this warning immediatelyPorter Stansberry, founder of one of the world's largest financial research firms, says he's breaking the biggest story of his 26-year career. A famous historian whose books have sold over 45 million copies in 65 languages is warning of a structural shift so large it has only one historical parallel - 1776. One Stanford economist calls it 'the biggest change ever - bigger than electricity, bigger than the steam engine.' Stansberry outlines the stocks to buy, the stocks to sell, and three money moves to position yourself on the right side of this shift.May 18 at 1:00 AM | Porter & Company (Ad)A Look At BioLife Solutions (BLFS) Valuation As Shares Show Recent Short Term MomentumMay 11, 2026 | finance.yahoo.comCraig-Hallum Sticks to Its Buy Rating for BioLife Solutions (BLFS)May 10, 2026 | theglobeandmail.comLake Street Sticks to Their Buy Rating for BioLife Solutions (BLFS)May 10, 2026 | theglobeandmail.comBioLife Solutions (NASDAQ:BLFS) Shares Gap Down - What's Next?May 10, 2026 | americanbankingnews.comBioLife (BLFS) Q1 2026 Earnings TranscriptMay 8, 2026 | fool.comSee More Headlines BLFS Stock Analysis - Frequently Asked Questions How have BLFS shares performed this year? BioLife Solutions' stock was trading at $24.18 at the beginning of the year. Since then, BLFS shares have decreased by 7.0% and is now trading at $22.4850. How were BioLife Solutions' earnings last quarter? BioLife Solutions, Inc. (NASDAQ:BLFS) released its quarterly earnings data on Thursday, May, 7th. The medical equipment provider reported $0.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.01 by $0.03. The medical equipment provider had revenue of $27.50 million for the quarter, compared to the consensus estimate of $25.66 million. BioLife Solutions had a negative net margin of 2.80% and a positive trailing twelve-month return on equity of 1.81%. Read the conference call transcript. Who are BioLife Solutions' major shareholders? Top institutional investors of BioLife Solutions include Dimensional Fund Advisors LP (2.12%), Granahan Investment Management LLC (1.48%), Stephens Investment Management Group LLC (1.39%) and Peregrine Capital Management LLC (0.71%). Insiders that own company stock include Casdin Partners Master Fund, L, Aby J Mathew, Greef Roderick De, Michael Rice, Troy Wichterman, Todd Berard, Garrie Richardson, Karen A Foster, Sarah Aebersold, Geraint Phillips, Sean Werner, Joydeep Goswami, Marcus Schulz and Amy Duross. View institutional ownership trends. How do I buy shares of BioLife Solutions? Shares of BLFS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of BioLife Solutions own? Based on aggregate information from My MarketBeat watchlists, some other companies that BioLife Solutions investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Netflix (NFLX), JPMorgan Chase & Co. (JPM) and Visa (V). Company Calendar Last Earnings5/07/2026Today5/18/2026Next Earnings (Estimated)8/06/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Yellow Zone (6d) 1-Year History May 25 Aug 25 Nov 25 Feb 26 May 26 For the last 6 days, BLFS's financial health has been in the Yellow zone, according to TradeSmith. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED PRODUCTS Sub-IndustryMedical Equipment Current SymbolNASDAQ:BLFS CIK834365 Webwww.biolifesolutions.com Phone(425) 402-1400Fax425-402-1433Employees440Year Founded1987Price Target and Rating Average Price Target for BioLife Solutions$32.00 High Price Target$34.00 Low Price Target$30.00 Potential Upside/Downside+45.3%Consensus RatingHold Rating Score (0-4)2.40 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($0.08) Trailing P/E RatioN/A Forward P/E Ratio244.78 P/E GrowthN/ANet Income-$4.59 million Net Margins-2.80% Pretax Margin-10.51% Return on Equity1.81% Return on Assets1.65% Debt Debt-to-Equity RatioN/A Current Ratio7.30 Quick Ratio5.50 Sales & Book Value Annual Sales$96.21 million Price / Sales11.19 Cash Flow$0.24 per share Price / Cash Flow90.66 Book Value$7.72 per share Price / Book2.85Miscellaneous Outstanding Shares48,860,000Free Float47,782,000Market Cap$1.08 billion OptionableOptionable Beta1.97 Social Links Analysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2026 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (NASDAQ:BLFS) was last updated on 5/18/2026 by MarketBeat.com Staff. From Our PartnersZENA Surges: 558% Revenue Growth Fuels Breakout Small-Cap Narrative!ZenaTech (NASDAQ: ZENA) reported $12.9 million in full-year 2025 revenue, representing 558% year-over-year gro...Equiscreen | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredYour $29.97 book is free todayBill Poulos is giving away his 'Safe Trade Options Formula' book at no charge - the same book that sells for $...Profits Run | SponsoredThe cat is out the bagAlmost 80,000 tech jobs vanished in the first three months of 2026. Meta cut 14,000 roles, Microsoft offered s...Porter & Company | SponsoredBefore you buy SpaceX shares, consider this alternative approachSpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceedin...Weiss Ratings | SponsoredThe Iran War Just Broke the Gold MarketThe Iran war isn't just a geopolitical event. It's a financial one. Within hours of the strikes, oil surged...Behind the Markets | SponsoredSpaceX just split its stock 5-for-1SpaceX just cut its share price from over $526 to roughly $105 with a 5-for-1 stock split - a move that signal...NXT Wave Research | SponsoredI had never heard of this 1888 accountAn investment account dating back to 1888 has quietly delivered average annual returns of 29% over the last 25...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLife Solutions, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLife Solutions With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
